Back to Search Start Over

Fractionating heparins and their clinical trial data-something for everyone

Authors :
Das, Pranab
Moliterno, David J.
Source :
JAMA, The Journal of the American Medical Association. July 7, 2004, Vol. 292 Issue 1, p101, 3 p.
Publication Year :
2004

Abstract

Heparin is known to reduce ischemic occurrences beyond that of aspirin in acute coronary setting and unfractionated heparin is known to have several limitations and inability to inhibit clot-bound thrombin. Trials show that enoxaparin is a good alternative to unfractionated heparin in regular acute coronary syndrome (ACS) treatment.

Subjects

Subjects :
Enoxaparin -- Dosage and administration
Enoxaparin -- Research
Coronary heart disease -- Care and treatment
Heparin -- Research
Heparin -- Dosage and administration

Details

Language :
English
ISSN :
00987484
Volume :
292
Issue :
1
Database :
Gale General OneFile
Journal :
JAMA, The Journal of the American Medical Association
Publication Type :
Academic Journal
Accession number :
edsgcl.122664881

Tools

Authors Abstract Subjects Details